ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 141 filers reported holding ACHILLION PHARMACEUTICALS IN in Q4 2016. The put-call ratio across all filers is 0.61 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $15,974,000 | -42.1% | 3,867,795 | +13.5% | 0.00% | -50.0% |
Q3 2016 | $27,600,000 | +17.1% | 3,407,376 | +12.8% | 0.00% | 0.0% |
Q2 2016 | $23,567,000 | +5.8% | 3,021,403 | +4.7% | 0.00% | 0.0% |
Q1 2016 | $22,273,000 | -29.2% | 2,885,145 | -1.1% | 0.00% | -20.0% |
Q4 2015 | $31,462,000 | +61.1% | 2,915,843 | +3.2% | 0.01% | +66.7% |
Q3 2015 | $19,528,000 | -18.9% | 2,826,073 | +4.0% | 0.00% | -25.0% |
Q2 2015 | $24,065,000 | -15.1% | 2,716,111 | -5.5% | 0.00% | 0.0% |
Q1 2015 | $28,344,000 | -8.6% | 2,874,639 | +13.6% | 0.00% | -20.0% |
Q4 2014 | $31,012,000 | +19.1% | 2,531,603 | -3.0% | 0.01% | +25.0% |
Q3 2014 | $26,043,000 | +12.2% | 2,609,565 | -14.9% | 0.00% | 0.0% |
Q2 2014 | $23,205,000 | +124.0% | 3,065,368 | -2.6% | 0.00% | +100.0% |
Q1 2014 | $10,358,000 | +4.4% | 3,148,196 | +5.3% | 0.00% | 0.0% |
Q4 2013 | $9,924,000 | +21.5% | 2,990,205 | +10.5% | 0.00% | 0.0% |
Q3 2013 | $8,169,000 | -58.5% | 2,704,904 | +12.4% | 0.00% | -50.0% |
Q2 2013 | $19,693,000 | – | 2,407,435 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RA Capital Management | 13,633,220 | $56,305,000 | 7.98% |
BVF INC/IL | 2,423,300 | $10,008,000 | 2.01% |
EMORY UNIVERSITY | 454,102 | $1,875,000 | 1.85% |
DAFNA Capital Management LLC | 196,500 | $812,000 | 0.71% |
Orbimed Advisors | 13,107,200 | $54,133,000 | 0.69% |
RTW INVESTMENTS, LP | 286,285 | $1,182,000 | 0.44% |
Marcus Capital, LLC | 100,000 | $413,000 | 0.44% |
Rock Springs Capital Management LP | 1,375,000 | $5,679,000 | 0.38% |
Spark Investment Management LLC | 978,600 | $4,041,000 | 0.33% |
Bellevue Group AG | 240,000 | $991,000 | 0.20% |